Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 7 | 2024 | 1853 | 0.720 |
Why?
|
| Hypothermia, Induced | 1 | 2019 | 164 | 0.550 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 369 | 0.470 |
Why?
|
| Weight Gain | 1 | 2017 | 377 | 0.450 |
Why?
|
| Monitoring, Physiologic | 2 | 2016 | 370 | 0.450 |
Why?
|
| Heart Arrest | 1 | 2019 | 362 | 0.440 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2016 | 140 | 0.430 |
Why?
|
| Coronary Care Units | 1 | 2013 | 31 | 0.410 |
Why?
|
| Critical Care | 3 | 2016 | 668 | 0.380 |
Why?
|
| Down Syndrome | 1 | 2013 | 200 | 0.340 |
Why?
|
| Hemodynamics | 1 | 2013 | 822 | 0.310 |
Why?
|
| Heart Diseases | 1 | 2013 | 490 | 0.300 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 457 | 0.290 |
Why?
|
| Obesity | 1 | 2017 | 2332 | 0.240 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3066 | 0.230 |
Why?
|
| Atrial Septum | 1 | 2025 | 19 | 0.230 |
Why?
|
| Fetal Heart | 1 | 2025 | 135 | 0.210 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2025 | 124 | 0.210 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2016 | 153 | 0.210 |
Why?
|
| Oximetry | 2 | 2016 | 174 | 0.210 |
Why?
|
| Health Information Systems | 2 | 2024 | 31 | 0.200 |
Why?
|
| Heart Failure | 1 | 2016 | 2289 | 0.190 |
Why?
|
| Teaching Rounds | 1 | 2022 | 30 | 0.190 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2025 | 269 | 0.190 |
Why?
|
| Cardiac Catheterization | 1 | 2025 | 629 | 0.170 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 442 | 0.170 |
Why?
|
| Heart Ventricles | 1 | 2024 | 761 | 0.150 |
Why?
|
| Asphyxia | 1 | 2019 | 12 | 0.150 |
Why?
|
| Linear Models | 2 | 2017 | 681 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2024 | 674 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2017 | 54 | 0.140 |
Why?
|
| Palivizumab | 1 | 2017 | 46 | 0.130 |
Why?
|
| Chlorothiazide | 1 | 2016 | 11 | 0.130 |
Why?
|
| Nephrons | 1 | 2016 | 16 | 0.130 |
Why?
|
| Diuresis | 1 | 2016 | 45 | 0.130 |
Why?
|
| Child Development | 1 | 2019 | 265 | 0.130 |
Why?
|
| Infant | 6 | 2024 | 12771 | 0.120 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2015 | 10 | 0.120 |
Why?
|
| Alprostadil | 1 | 2015 | 22 | 0.120 |
Why?
|
| Humans | 14 | 2025 | 126753 | 0.120 |
Why?
|
| Hospitalization | 1 | 2024 | 1874 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 228 | 0.120 |
Why?
|
| Cardiac Output | 1 | 2016 | 161 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2019 | 557 | 0.110 |
Why?
|
| Length of Stay | 2 | 2024 | 1377 | 0.110 |
Why?
|
| Heart | 1 | 2019 | 650 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2025 | 3586 | 0.110 |
Why?
|
| Consensus | 1 | 2017 | 555 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 202 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 718 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17005 | 0.110 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2013 | 16 | 0.100 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2017 | 357 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2024 | 8347 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 534 | 0.100 |
Why?
|
| Critical Illness | 1 | 2016 | 604 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2017 | 1654 | 0.090 |
Why?
|
| Female | 9 | 2025 | 68330 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2016 | 826 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2025 | 12546 | 0.080 |
Why?
|
| Pregnancy | 2 | 2025 | 7373 | 0.080 |
Why?
|
| Male | 8 | 2024 | 62543 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2225 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2024 | 14347 | 0.060 |
Why?
|
| Child | 3 | 2024 | 25101 | 0.050 |
Why?
|
| Brain | 1 | 2016 | 3038 | 0.050 |
Why?
|
| Prognosis | 1 | 2013 | 4772 | 0.050 |
Why?
|
| Ductus Arteriosus | 1 | 2024 | 61 | 0.050 |
Why?
|
| Young Adult | 1 | 2017 | 9665 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1595 | 0.050 |
Why?
|
| Propensity Score | 1 | 2024 | 250 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2022 | 95 | 0.050 |
Why?
|
| Gestational Age | 1 | 2025 | 1186 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2024 | 489 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1047 | 0.040 |
Why?
|
| Family | 1 | 2022 | 575 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2022 | 497 | 0.040 |
Why?
|
| Texas | 2 | 2019 | 3551 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5114 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2022 | 550 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 10555 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 964 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2022 | 775 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 30410 | 0.030 |
Why?
|
| Furosemide | 1 | 2016 | 34 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 240 | 0.030 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2017 | 149 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2017 | 448 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 300 | 0.030 |
Why?
|
| Birthing Centers | 1 | 2015 | 9 | 0.030 |
Why?
|
| Diuretics | 1 | 2016 | 153 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6134 | 0.030 |
Why?
|
| Morbidity | 1 | 2015 | 245 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1137 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1374 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2017 | 757 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3251 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 1162 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11310 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 20002 | 0.020 |
Why?
|